방사선종양학

본문글자크기
  • [Int J Radiat Oncol Biol Phys.] What Is High-risk Breast Cancer With Pathologically Negative Lymph Nodes for Regional Recurrence? 림프절 음성 유방암 환자에서 영역재발의 고위험군은?

    아주의대,성균관의대 / 김상원, 조원경, 전미선*, 박원*

  • 출처
    Int J Radiat Oncol Biol Phys.
  • 등재일
    2021 Nov 15
  • 저널이슈번호
    111(4):992-998. doi: 10.1016/j.ijrobp.2021.07.005.
  • 내용

    바로가기  >

    Abstract
    Purpose: This study aimed to identify high-risk factors for regional recurrence in patients with breast cancer with pathologically negative lymph nodes.

    Methods and materials: We retrospectively analyzed 3800 patients with stage pT1-pT3 breast cancer and pathologically negative lymph nodes between 2004 and 2012. All patients underwent upfront surgery with curative intent. Adjuvant systemic treatments were administered to most patients (96.7%) based on contemporary guidelines.

    Results: After a median follow-up of 83 months (range, 7-175 months), the estimated 10-year cumulative incidence rate of regional recurrence was 2.0%. Multivariate competing risk analysis revealed that high histologic grade, positive lymphovascular invasion, and stage pT2-3 were significant risk factors for any regional recurrence. Patients with ≥2 risk factors showed a significantly higher 10-year cumulative incidence rate of any regional recurrence than those with 1 or no risk factors (5.5% vs 1.2%; P < .001). When the number of retrieved lymph nodes was less than 10, the difference in the incidence rate of regional recurrence between patients with ≥2 risk factors and those with 1 or no risk factors was greater (6.6% vs 1.3%, respectively; P < .001). The 10-year disease-free survival was worse in patients with ≥2 risk factors than in those with 1 or no risk factors (84.7% vs 90.0%, respectively; P < .001). Patients with ≥2 risk factors also showed worse 10-year overall survival than did those with 1 or no risk factors (91.3% vs 97.0%, respectively; P < .001).

    Conclusions: Overall, the cumulative incidence rate of any regional recurrence was low at 10 years. However, patients with ≥2 risk factors showed an increased risk of any regional recurrence and worse disease-free survival, particularly when the number of retrieved lymph nodes was less than 10.

     

     

     

    Affiliations

    Sang-Won Kim  1 , Won Kyung Cho  2 , Doo Ho Choi  2 , Haeyoung Kim  2 , Oyeon Cho  3 , Won Park  4 , Mison Chun  5
    1 Department of Radiation Oncology, Konyang University College of Medicine, Daejeon, Republic of Korea; Myunggok Medical Research Institute, Konyang University College of Medicine, Daejeon, Republic of Korea.
    2 Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
    3 Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
    4 Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Electronic address: wonro.park@samsung.com.
    5 Department of Radiation Oncology, Ajou University School of Medicine, Suwon, Republic of Korea. Electronic address: chunm@ajou.ac.kr.

  • 편집위원

    림프절 음성 유방암에서 영역림프절 재발의 위험인자를 분석함으로써, 예방적 영역림프절조사의 적응증을 제안하고자 한 연구

    2022-01-04 17:34:55

  • 덧글달기
    덧글달기
       IP : 3.236.138.35

    등록